Cost of allogeneic bone marrow transplantation in four diseases.
The cost of bone-marrow transplantation is compared in 4 diseases: acute myelogenous leukaemia, severe combined immunodeficiency, severe aplastic anaemia and chronic granulocytic leukaemia. Hospital cost components directly related to the clinical protocols applied are valorized. Results confirm the well-known fact that bone-marrow transplantation is a costly technique. The unit cost of a transplantation can vary from 1 to 2 between departments for the sole reason that patients treated are not suffering from the same illness. For one disease, the unit cost may vary from 1 to 2.7 when post-graft complications arise. Furthermore, in the health-care sector, as well as in every other economic sector, costs do not remain stable: they vary in time most especially when treatment protocols evolve. This type of cost information is the basis for management control systems without which physicians, hospital managers and health-care authorities cannot communicate effectively. In countries where health care is largely financed by the community, what is at stake is the future of advanced technologies in medicine.
D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000601:surgery; D000741:Anemia, Aplastic / Q000191:economics / Q000601:surgery; D016026:Bone Marrow Transplantation; D003365:Costs and Cost Analysis; D005069:Evaluation Studies as Topic; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000191:economics / Q000601:surgery; D015470:Leukemia, Myeloid, Acute / Q000191:economics / Q000601:surgery; D010297:Paris; D014184:Transplantation, Homologous / Q000191:economics*